Physician profile
Jon Williams
NPI 1316385529
$31,071.90
in general payments reported to CMS, 2019-2025
22 companies · $5,792 in 2025
The $5,792 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $159 · 2021: $1,953 · 2022: $5,407 · 2023: $5,702 · 2024: $12K · 2025: $5,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,900 · Food and Beverage: $3,071 · Travel and Lodging: $2,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,900.00 |
| Food and Beverage | $3,070.80 |
| Travel and Lodging | $2,373.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,730.84 | 2020-2024 | Davinci Xi, Da Vinci Surgical System |
| Lucid Diagnostics INC. | $3,947.29 | 2024-2025 | |
| Medtronic, INC. | $3,555.92 | 2021-2025 | Signia, Endoflip, Barrx |
| Medical Device Business Services, INC. | $839.43 | 2025 | Linx Reflux Management System |
| Endogastric Solutions, INC | $640.02 | 2021-2024 | Esophyx |
| Davol INC. | $628.50 | 2023-2024 | Phasix Mesh |
| Intra-Sana Laboratories | $510.16 | 2022-2024 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Apollo Endosurgery US INC | $330.78 | 2021-2023 | Orbera Intragastric Balloon System, Overstitch Endoscopic Suturing System |
| Ethicon US, LLC | $206.68 | 2021-2025 | Echelon; Endopath, Linx Reflux Management System |
| Covidien LP | $161.69 | 2019-2020 | |
| Ambu INC. | $125.67 | 2023 | |
| Acell, INC. | $107.46 | 2019 | |
| Acera Surgical, INC. | $84.84 | 2021-2024 | Restrata Wound Matrix |
| Tela Bio, INC. | $44.14 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $33.62 | 2022-2023 | Seglentis |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $24.23 | 2021 | |
| Conmed Corporation | $19.81 | 2022 | |
| Reshape Lifesciences INC. | $19.44 | 2024 | |
| Innocoll Pharmaceuticals Limited | $18.36 | 2021 | |
| Integra Lifesciences Corporation | $16.01 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| E.R. Squibb & Sons, L.L.C. | $14.06 | 2019 | |
| Olympus America INC. | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.